Prevention of RSV disease in babies starts again at HUS hospitals

HUS will offer the antibody to newborns in all its maternity hospitals from August 17, 2026. In addition, children under the age of 12 months who are at risk for a severe RSV disease will be offered the antibody at HUS New Children's Hospital, Jorvi Hospital, and Hyvinkää Hospital when they visit specialized healthcare.

The aim is to prevent the majority of severe illnesses and infant hospitalizations caused by RSV. Immunization with the antibody is voluntary and free of charge for families.  

The antibody is effective at preventing RSV infections: reduces infant hospitalization

The antibody can be administered even to newborns. The antibody provides effective protection against RSV for the entire winter epidemic. The product is very safe.

The antibody has already been used in Finland for two winter seasons, and the results have been excellent, as they have been in other countries where the antibody has been introduced. At HUS, around 90% of families have opted to have their child receive the antibody.

The antibody reduces the severity of RSV symptoms so significantly that severe cases of RSV in infants nearly disappear. Thanks to the antibody, the number of infant hospitalization days due to RSV reduced by 90% at HUS hospitals.